What we are studying
The purpose of this research study is to find out what effects (good and bad) LY3154207 has on a person and his/her condition (Parkinson's disease with dementia). The main reason for anyone to take part in this study is not to treat a condition but to help in answering the following research question: How does LY3154207 compare with placebo in treating memory and thinking problems
in individuals with mild-to-moderate Parkinson’s disease dementia? LY3154207 is an investigational drug that is not approved by the FDA.
You will received compensation for each visit completed.